2 completed. .
Follow Light Chain Nephropathy: new trials by email Literature Review of Light Chain Nephropathy trials Research Report on Light Chain Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biomarkers of AKI in Patients Receiving Daratumumab Daratumumab - Acute Kidney Injury, Multiple Myeloma | Completed | Brigham and Women's Hospital | 20 | 2024-09-01 | 2026-02-27 | |
| Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy Plasma exchange, Daratumumab - Multiple Myeloma, Light Chain Nephropathy | Completed | Brigham and Women's Hospital | 549 | 2024-06-01 | 2026-07-09 |
Acute Kidney Injury (2) · Multiple Myeloma (2)
Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Kidney Diseases (2) · Lymphoproliferative Disorders (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
daratumumab (2) · Plasma Exchange (1)
Brigham and Women's Hospital (2)
United States (2)
Shruti Gupta, MD (1)